|
|
||||||||
1 The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104; and 2 Program of Cell and Molecular Biology, Biomedical Graduate Studies, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
* corresponding author, herlynm{at}wistar.upenn.edu
Melanoma development not only involves genetic and epigenetic changes that take place within the cell, but also involves processes determined collectively by micro-environmental factors, including cell-cell interactions and communications. During the transition from normal cells to benign and malignant lesions, and subsequently to metastatic cancer, stepwise changes in intercellular communications provide tumor cells with the ability to overcome cell-cell adhesion and micro-environmental controls from the host and to invade surrounding tissues and disperse to distant locations. Cadherins are major cellcell adhesion molecules involved in the development and maintenance of skin. E-cadherin expressed in normal melanocytes mediates growth and invasion control by keratinocytes. Progressive loss of E-cadherin and gain of N-cadherin during melanoma development not only free melanoma cells from control by keratinocytes, but also provide new adhesion properties, resulting in switched partnerships with fibroblasts and vascular endothelial cells. The cadherin subtype switching also dictates gap junctional specificity in melanocytic cells during tumor development. This selective intercellular communication may contribute to the regulation of cell growth, differentiation, apoptosis, and migration of melanocytic cells in both physiologic and pathologic conditions. Abnormal up-regulation of the immunoglobin repeat-containing cell adhesion molecules Mel-CAM and L1-CAM potentiates invasion and migration of melanoma. Thus, abnormal expression of intercellular adhesion receptors and dysregulated intercellular communication underlies melanoma development and progression.
Key words. Intercellular communication, melanoma, cell junction, tumor progression
This article has been cited by other articles:
![]() |
Z.-J. Liu, M. Xiao, K. Balint, K. S.M. Smalley, P. Brafford, R. Qiu, C. C. Pinnix, X. Li, and M. Herlyn Notch1 Signaling Promotes Primary Melanoma Progression by Activating Mitogen-Activated Protein Kinase/Phosphatidylinositol 3-Kinase-Akt Pathways and Up-regulating N-Cadherin Expression. Cancer Res., April 15, 2006; 66(8): 4182 - 4190. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Haass, E. Wladykowski, S. Kief, I. Moll, and J. M. Brandner Differential Induction of Connexins 26 and 30 in Skin Tumors and Their Adjacent Epidermis J. Histochem. Cytochem., February 1, 2006; 54(2): 171 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Klaile, M. M. Muller, C. Kannicht, B. B. Singer, and L. Lucka CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration J. Cell Sci., December 1, 2005; 118(23): 5513 - 5524. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, M. A. Price, C. L. Neudauer, C. Wilson, S. Ferrone, H. Xia, J. Iida, M. A. Simpson, and J. B. McCarthy Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms J. Cell Biol., June 21, 2004; 165(6): 881 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. HAZAN, R. QIAO, R. KEREN, I. BADANO, and K. SUYAMA Cadherin Switch in Tumor Progression Ann. N.Y. Acad. Sci., April 1, 2004; 1014(1): 155 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herlyn, M. Padarathsingh, L. Chin, M. Hendrix, D. Becker, M. Nelson, Y. DeClerck, J. McCarthy, and S. Mohla New Approaches to the Biology of Melanoma: A Workshop of the National Institutes of Health Pathology B Study Section Am. J. Pathol., November 1, 2002; 161(5): 1949 - 1957. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® | Journal of Dental Research ® | Critical Reviews (1990-2004) |